Pinealon

Overview

Pinealon is part of the Khavinson “short peptide bioregulator” series — tripeptides derived from tissue-specific extracts designed to provide organ-targeted gene regulation. Like other members of this series, it has a substantial publication record from a single Russian research group but limited independent validation.

Pineal Gland Connection

The derivation from pineal gland tissue connects pinealon conceptually to melatonin, circadian biology, and the neuroendocrine aging literature. Whether the tripeptide specifically recapitulates pineal bioregulation or simply has generic neuroprotective effects is unclear.

Retinal Application

One of the more interesting research directions for pinealon is diabetic retinopathy — a major complication of diabetes that represents a significant unmet medical need. The animal data suggests neuroprotective effects in retinal neurons, though human translation is unestablished.

Evidence Standard

Consistent with other Russian bioregulator peptides, the evidence for pinealon meets a lower methodological standard than would be required for regulatory approval in Western markets. The data is suggestive but cannot be considered definitive.